Research to make early detection of Alzheimer’s disease more accessible

By combining a simple blood test with a cognitive exam and demographics, researchers at UNT Health Science Center were able to accurately detect Alzheimer’s disease, even in its very early stages.

The research could lead to a rapid, accurate and cost-effective way to screen for Alzheimer’s disease, said Dr. Sid O’Bryant, Interim Director of the Institute for Aging and Alzheimer’s Disease Research and one of four authors of the study in the Journal of Alzheimer’s Disease.

"We’re talking about one finger stick and a short cognitive test," Dr. O’Bryant said.  "Every patient 60 and older could get it once a year from their primary care doctor."

For the study, only two blood biomarkers were screened. The Clock Drawing Test, which requires participants to place the hands and numbers on a predetermined time, was used for the cognitive exam.

The combination of tests could make early detection more accessible to the growing population of people at risk for Alzheimer’s disease. Currently 5.2 million people have Alzheimer’s disease, but that number is expected to triple by 2050.

The prevalence of Alzheimer’s disease has led to a heightened interest in finding an accurate tool for early detection. Earlier treatment helps preserve function and leads to better outcomes, Dr. O’Bryant said.

The model could be used to screen for the disease before more expensive, time-consuming and invasive procedures are considered.

"Instead of a comprehensive dementia exam, which takes two hours, this entire process can be done in less than 10 minutes," Dr. O’Bryant said. "Then if you get a positive result, you can do a full blown blood test and brain scan."

It also would make screening available to more people.

"The problem now is there are far more elders who should be screened for cognitive loss than there is capacity," Dr. O’Bryant said. "This is cost effective, time effective, and it won’t over-burden the health care system."

The financial burden for Alzheimer’s disease is estimated at $200 billion but that could reach $1.1 trillion by 2050.

Dr. James Hall, Professor of Psychiatry and Behavioral Health also participated in the research. Melissa Edwards, a PhD student in the psychology department at UNT was lead author on the study.

Recent News

Selina Tucker Hsc Sbs
  • Research
|May 7, 2024

SBS students earn awards for outstanding cardiovascular research

The School of Biomedical Sciences has announced new student awards and an upcoming symposium to support and enhance translational cardiovascular research at The University of North Texas Health Science Center at Fort Worth.   SBS students Selina Tucker and Lindsey Hudson are recipients of the i...
Reunion 3852
  • Our People
|May 7, 2024

TCOM’s Class of 1980 returns home to reminisce and celebrate

A tight-knit group from the first day they set foot on campus in 1976, the Texas College of Osteopathic Medicine’s Class of 1980 reunited for the first time in 44 years as they celebrated together on the campus of The University of North Texas Health Science Center at Fort Worth. The reunion, spea...
Physical therapy career fair attendee
  • On Campus
|May 6, 2024

Physical therapy career fair largest ever on campus

The first floor of IREB was a maze of banners and tables manned by prospective employers. As around 200 physical therapy students filtered through the career fair, organized by The University of North Texas Health Science at Fort Worth’s Career Readiness Center, students and community partners rep...
Heads Up
  • Our People
|May 3, 2024

Pharmaceutical sciences faculty awarded patents

Two members of The University of North Texas Health Science Center at Fort Worth’s College of Pharmacy faculty have made significant strides in their respective fields. Dr. Kyle Emmitte, an expert in medicinal chemistry, and Dr. Jin Liu, specializing in computational drug design, joined forces on ...